Canadian Pharmacare: Performance, Incentives, and Insurance
This paper discusses differences between provincial drug plans with respect to breadth of coverage and cost sharing between patients and taxpayers, and introduces two new measurements to describe how provincial Pharmacare plans perform as insurers and how generous they are to their beneficiaries. Finally, we compare these measurements with provinces' spending on their prescription benefit plans and consider which provinces get most value for their taxpayers' money.
More from this study
Subscribe to the Fraser Institute
Get the latest news from the Fraser Institute on the latest research studies, news and events.